West Pharmaceutical Services EV/EBIT WST

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2011.

Today, Oct 23, 2026: 39.5×
10-year median: 34.7×
Against its 10-year history: 73rd; percentile: 0 is its lowest day, 100 its highest
10-year range: 19.5× to 63.2×
Peer median: 18.0×

West Pharmaceutical Services' EV/EBIT is 39.5× as of Oct 23, 2026.

That is above its ten-year median of 34.7×, higher than on 73% of days in the last ten years.

Over that time it ranged from 19.5× in Nov 2022 to 63.2× in Oct 2020.

The median for 10 medical instruments and supplies stocks of a similar size is 18.0×.

EV/EBIT over time

median 34.7×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	39.5×	27.3×	39.5×
2025	32.6×	25.3×	43.1×
2024	41.6×	34.4×	45.1×
2023	38.6×	21.1×	44.5×
2022	21.4×	19.5×	42.7×
2021	50.1×	43.0×	59.7×
2020	55.0×	31.5×	63.2×
2019	37.5×	29.4×	38.2×
2018	29.0×	27.1×	37.3×
2017	32.6×	24.1×	34.8×
2016	27.4×	24.4×	40.9×
2015	34.3×	20.5×	36.5×
2014	22.4×	17.4×	23.4×
2013	22.8×	15.3×	24.0×
2012	15.1×	13.4×	17.2×
2011	15.5×	14.7×	19.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest West Pharmaceutical Services' size, closest first, today.

Company	EV/EBIT
WSTWest Pharmaceutical Services	39.5×
RMDResMed	18.7×
MDLNMedline	n/m
SOLVSolventum	8.4×
BDXBecton, Dickinson and	22.1×
PENPenumbra	65.8×
COOCooper Companies	17.2×
ALGNAlign Technology	16.2×
GMEDGlobus Medical	16.3×
PODDInsulet	20.4×
MSAMSA Safety	18.0×
Peer median	18.0×

Where West Pharmaceutical Services ranks

#36of 46Medical instruments and supplies stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on West Pharmaceutical Services

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.